drugset
Drugs / Influenza A/H5N1 Vaccine
last change Sep 2024 re-read 2 minutes ago

Influenza A/H5N1 Vaccine

also known as H3N2v MIV · IIV · Inactivated Influenza A/H7N7 Vaccine · Influenza A/H3N2 variant Vaccine · Influenza A/H5N1 · Influenza A/H7N7 Vaccine · Influenza A/H9N2 vaccine · Influenza A/Vietnam/1203/2004 (H5N1)

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 9 · a red edge is where a trial was stopped

today NCT01746082 · Ph 2 NCT01573312 · Ph 1 NCT00546585 · Ph 1/2 NCT00133536 · Ph 1/2 NCT00230750 · Ph 1/2 NCT00311727 · not/applicable NCT00240903 · Ph 1 NCT00133471 · Ph 1/2 NCT00115986 · Ph 1/2
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT01573312 May 2012 → Jan 2014 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 1 NCT00240903 Oct 2005 → Mar 2006 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 1/25 trials
Phase 1/2 NCT00546585 Mar 2008 → Feb 2009 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 1/2 NCT00133536 Jan 2006 → Apr 2007 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 1/2 NCT00230750 Oct 2005 → Jan 2007 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 1/2 NCT00133471 Mar → Dec 2005 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 1/2 NCT00115986 Mar 2005 → Feb 2006 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase 21 trial
Phase 2 NCT01746082 Jan → Aug 2013 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Phase not applicable1 trial
— NCT00311727 Oct 2005 → Mar 2006 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 10 sources stand behind the page.

FieldValueCited text
Known as Influenza A/H5N1 Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00133536 ↗
3

NCT00230750 ↗

NCT00115986 ↗

NCT01573312 ↗
Known as H3N2v MIV “Subjects will be stratified by age (approximately 100 (up to 120) subjects 18-64 years old and approximately 100 (up to 120) subjects \>/= 65 years old) to receive two doses of...” NCT01746082 ↗
Known as IIV “Twenty healthy men and women (18-49 years of age) were randomized to receive 2 doses of inactivated influenza A/H5N1 vaccine alone (IIV) or with AS03 adjuvant (IIV-AS03) 1 month apart.” PMID 38181048 ↗ Sep 2024
Known as Inactivated Influenza A/H7N7 Vaccine “experimental flu vaccine \[Inactivated Influenza A/H7N7 Vaccine\]” NCT00546585 ↗
Known as Influenza A/H3N2 variant Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01746082 ↗
Known as Influenza A/H5N1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00311727 ↗
Known as Influenza A/H7N7 Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00546585 ↗
Known as Influenza A/H9N2 vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00133471 ↗
Known as Influenza A/Vietnam/1203/2004 (H5N1) “Influenza A/Vietnam/1203/2004 (H5N1; sanofi pasteur)” NCT00240903 ↗
Modality Vaccine “inactivated influenza A/H5N1 vaccine” NCT00115986 ↗
Route Intramuscular “by intramuscular injection” NCT00115986 ↗